User

Ortivus AB (publ)

ORTI-B.ST

Medical - Instruments & Supplies · Healthcare

Price

kr 1.80

+0.00 (+0.00%)

Market Cap

kr 79.7M

Exchange

Stockholm Stock Exchange

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Winston Score below 40. The stock fails on most of our quality checks.

Ortivus is a Swedish medical technology company that makes software and systems for monitoring patients in emergency and cardiac care settings. Its main products help ambulances and hospitals track heart data in real time, so doctors can prepare before a patient even arrives. The company sells primarily to emergency medical services and hospitals across Scandinavia and the United Kingdom.

Ortivus earns revenue mainly through software licenses and service contracts with healthcare providers, giving it some recurring income. It is a small company with a market cap around $100 million, and its edge comes from specialized software that integrates with existing hospital workflows, which makes switching costly for customers. However, the company is currently losing money at the operating level, and its biggest challenge is scaling revenue fast enough to cover its cost base while competing against larger medical technology firms with deeper resources.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+18.4% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+97.3% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$8M/ year

↓ Declining (-29% vs prior year)

10.5% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

22.6%ownership

Insiders own a meaningful stake in the company

Cash Runway

~1 months

$7M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

Ortivus AB (publ) has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

46.7%

Healthy — 46.7% gross margin

Operating Margin

-3.8%

Losing money on operations — -3.8%

ROCE

-1.7%

Weak — -1.7% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+0.3%

Nearly flat sales (0.3% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

-66.1%

Burning cash (-66.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

1.23

Elevated debt (1.23)

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial